Effect of Evidence-Based Pharmacy Care on Satisfaction and Cognition in Patients with Non-Valvular Atrial Fibrillation Taking Rivaroxaban

References

• Hindricks G, Potpara T, Dagres N, et al. ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020;42(5):373–498.
   Web of Science ®Google Scholar
• Benjamin EJ, Muntner P, Alonso A, et al.; American Heart Association Council on Epidemiology and Prevention Statistics. Committee and stroke statistics subcommittee. Heart disease and stroke statistics −2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–e528.
   PubMed Web of Science ®Google Scholar
• Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837–847. doi:10.1161/CIRCULATIONAHA.113.005119
   PubMed Web of Science ®Google Scholar
• Colilla S, Crow A, Petkun W, et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the US adult population. Am J Cardiol. 2013;112(8):1142–1147. doi:10.1016/j.amjcard.2013.05.063
   PubMed Web of Science ®Google Scholar
• Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34(35):2746–2751. doi:10.1093/eurheartj/eht280
   PubMed Web of Science ®Google Scholar
• Zhou Z, Hu D. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. J Epidemiol. 2008;18(5):209–216. doi:10.2188/jea.JE2008021
   PubMed Web of Science ®Google Scholar
• Kishore A, Vail A, Majid A, et al. Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Stroke. 2014;45(2):520–526. doi:10.1161/STROKEAHA.113.003433
   PubMed Web of Science ®Google Scholar
• Henriksson KM, Farahmand B, Åsberg S, et al. Comparison of cardiovascular risk factors and survival in patients with ischemic or hemorrhagic stroke. Int J Stroke. 2012;7(4):276–281. doi:10.1111/j.1747-4949.2011.00706.x
   PubMed Web of Science ®Google Scholar
• Grond M, Jauss M, Hamann G, et al. Improved detection of silent atrial fibrillation using 72-hour Holter ECG in patients with ischemic stroke: a Prospective Multicenter Cohort Study. Stroke. 2013;44(12):3357–3364. doi:10.1161/STROKEAHA.113.001884
   PubMed Web of Science ®Google Scholar
• Fatemi O, Yuriditsky E, Tsioufis C, et al. Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus(from the action to control cardiovascular Risk in Diabetes Study). Am J Cardiol. 2014;114(8):1217–1222. doi:10.1016/j.amjcard.2014.07.045
   PubMed Web of Science ®Google Scholar
• Lin KJ, Cho SI, Tiwari N, et al. Impact of metabolic syndrome on the risk of atrial fibrillation recurrence after catheter ablation: systematic review and meta-analysis. J Interv Card Electrophysiol. 2014;39(3):211–223. doi:10.1007/s10840-013-9863-x
   Web of Science ®Google Scholar
• Chang SH, Wu LS, Chiou MJ, et al. Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies. Cardiovasc Diabetol. 2014;13(1):123. doi:10.1186/s12933-014-0123-x
   PubMed Web of Science ®Google Scholar
• Nguyen TN, Hilmer SN, Cumming RG. Review of epidemiology and management of atrial fibrillation in developing countries. Int J Cardiol. 2013;167(6):2412–2420. doi:10.1016/j.ijcard.2013.01.184
   PubMed Web of Science ®Google Scholar
• Etminan M, Wright JM, Carleton BC. Evidence based pharmacotherapy: review of basic concepts and applications in clinical practice. Ann Pharmacother. 1998;32(11):1193–1200. doi:10.1345/aph.17333
   Web of Science ®Google Scholar
• Siyan Z. Evidence-based medicine and evidence-based pharmacy practice. J Clin Pharmacother. 2008;6(3):47.
   Google Scholar
• Theresa LC, Tamara D, Ross TT. Systematic reviews of pharmacy practice research: methodologic issues in searching evaluating, interpreting, and disseminating results. Ann Pharmacother. 2009;43(1):118–122.
   Web of Science ®Google Scholar
• John CA, Lip Gregory YH, De CR, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21):1385–413.
   Google Scholar
• Chen Z, Zhang M. A review of the 2014 AHA/ACC/HRS guidelines for the management of atrial fibrillation. J Clin Cardiol. 2014;30(11):929–931.
   Google Scholar
• Toklu HZ. Promoting evidence-based practice in pharmacies. Integr Pharm Res Pract. 2015;4:127–131. PMID: 29354526; PMCID: PMC5741015. doi:10.2147/IPRP.S70406
   Google Scholar
• Cook DA, Beckman TJ. Current concepts in validity and reliability for psychometric instruments: theory and application. Am J Med. 2006;119(2):166.e7–166.16. doi:10.1016/j.amjmed.2005.10.036
   Google Scholar
• Yu M. Development of a transition process scale for high-risk infant’s caregiver. Iran J Public Health. 2016;45(2):158–169.
   Web of Science ®Google Scholar
• Shi J, Mo X, Sun Z. Application of content validity index in scale formulation. J Cent South Univ. 2012;37(2):152–155.
   Google Scholar
• Minglong WU. Practice of Questionnaire Statistical Analysis: SPSS Operation and Application. Chongqing: Chongqing University Press; 2010:476–477.
   Google Scholar
• Wiedenmayer K, Summers R, Mackie C, Gous A, Everard M, Tromp D. Developing pharmacy practice: a focus on patient care. World Health Organization; International Pharmaceutical Federation; 2006.
   Google Scholar
• Albrecht S. Evidence-based medicine in pharmacy practice. US Pharmacist. 2009;34(10):HS14–HS18.
   Google Scholar
• Schindler B, Gointher J, Suter K. Qualitätsbewertung klinischer Studien [Evidence-based pharmacy – assessment of study quality]. Med Monatsschr Pharm. 2014;37(11):413–418. German.
   Google Scholar
• Wiedenmayer K, Summers RS, Mackie CA, Gous AG, Everard M, Tromp D. Developing Pharmacy Practice – Focus Patient Care. Netherlands: World Health Organization and International Pharmaceutical Federation; 2006.
   Google Scholar
• Toklu HZ, Hussain A. The changing face of pharmacy practice and the need for a new model of pharmacy education. J Young Pharm. 2013;5(2):38–40. doi:10.1016/j.jyp.2012.09.001
   PubMedGoogle Scholar
• Medlinskiene K, Richardson S, Fylan B, et al. Patient perspectives on factors affecting direct oral anticoagulant use for stroke prevention in atrial fibrillation. Patient Prefer Adherence. 2021;15:953–966. doi:10.2147/PPA.S302016
   Web of Science ®Google Scholar
• Paudyal V, Cadogan C, Fialová D, et al. Provision of clinical pharmacy services during the COVID-19 pandemic: experiences of pharmacists from 16 European countries. Res Social Adm Pharm. 2020;17(8):1507–17.
   Web of Science ®Google Scholar
• Han AL. Study on the application value of evidence-based pharmacy to drug adverse reactions. Electron J Clin Med Lit. 2018;5(16):152.
   Google Scholar
• Yao JJ. Effect of evidence-based pharmacy on rational use of antibiotics in clinic. Medicine. 2016;3:145.
   Google Scholar
• Jia X, Zhou S, Luo D, et al. Effect of pharmacist-led cares on medication adherence and inhalation technique in adult patients with asthma or COPD: a systematic review and meta-analysis. J Clin Pharm Ther. 2020;45(5):904–917. doi:10.1111/jcpt.13126
   PubMed Web of Science ®Google Scholar
• Zhang LL, Yi L, Die HU, et al. Systematic review of evidence-based pharmacy definitions and literature. J CN EBM. 2011;11(1):7–13.
   Google Scholar